Bumper Offer - Urjas oil Just @ Rs. 1
Mefrin is an allopathic medicine The correct dosage of Mefrin depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Mefrin is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Mefrin is used -
Severe
Moderate
Mild
Is the use of Mefrin safe for pregnant women?
Mefrin can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Mefrin safe during breastfeeding?
Taking Mefrin may lead to serious side effects if you are breastfeeding. Mefrin should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Mefrin on the Kidneys?
Mefrin has very mild side effects on the kidneys.
What is the effect of Mefrin on the Liver?
Mefrin is rarely harmful for the liver.
What is the effect of Mefrin on the Heart?
Mefrin may have mild side effects on the heart. Most people will never see any effect on the heart.
Mefrin should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Mefrin unless your doctor advises you to do so -
Is this Mefrin habit forming or addictive?
Mefrin does not cause addiction.
Interaction between Food and Mefrin
You can take Mefrin with food.
Interaction between Alcohol and Mefrin
Taking Mefrin with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 118
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ponstel® (Mefenamic Acid)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 118
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ponstel® (Mefenamic Acid)
